Overview

Clinical Efficacy Study of Pucotenlimab Combined With Neoadjuvant Chemotherapy in Advanced Endometrial Cancer

Status:
NOT_YET_RECRUITING

Trial end date:
2029-12-01

Target enrollment:

Participant gender:

Summary

Exploring the therapeutic effect of neoadjuvant chemotherapy combined with PD-1 inhibitors on advanced stage III-IV endometrial cancer

Phase:

PHASE2

Details

Lead Sponsor:

Women's Hospital School Of Medicine Zhejiang University

Collaborators:

Anhui Provincial Cancer Hospital
First Affiliated Hospital of Wenzhou Medical University
Henan Provincial People's Hospital
Hunan Cancer Hospital
Ningbo No. 1 Hospital
Qilu Hospital of Shandong University
Sichuan Cancer Hospital and Research Institute
The First Affiliated Hospital of Zhengzhou University
Tongji Hospital
Xiangya Hospital of Central South University
Zhejiang Cancer Hospital

Treatments:

Carboplatin
Paclitaxel
Surgical Procedures, Operative